Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Lexicon Pharmaceuticals Inc (LXRX)  
$2.19 0.21 (10.61%) as of 4:30 Wed 3/27


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 188,730,000
Market Cap: 413.32(M)
Last Volume: 790,925 Avg Vol: 788,670
52 Week Range: $1 - $3.58
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Diagnostic Substances

Member Indexes:

    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    : 14
Insider 3/6 Months : 14.6
Guru Rank Number :  629
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Lexicon Pharmaceuticals is a biopharmaceutical company. Co. discovers the functions and pharmaceutical utility of genes and uses those gene function discoveries in the discovery and development of pharmaceutical products for the treatment of human disease. Co. is also developing sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes. Co. is developing LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain. In addition, Co. is conducting preclinical research and development and preparing to conduct clinical development of compounds from several additional drug programs.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 1,300,000 29,171,050 48,900,910
Total Buy Value $0 $1,410,373 $73,835,385 $123,160,035
Total People Bought 0 3 6 6
Total Buy Transactions 0 6 14 18
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2023-12-28 2023-09-26 2023-03-28 2022-03-28

   
Records found: 301
  Page 1 of 13  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Invus Advisors, L.l.c.   –       •       •   2024-03-13 4 A $108.50 $124,875,037 I/I 1,150,922 1,150,922     -
   Coats Lonnel Chief Executive Officer   •       •      –    2024-02-28 4 D $2.62 $160,792 D/D (61,371) 1,098,068     -
   Coats Lonnel Chief Executive Officer   •       •      –    2024-02-28 4 OE $0.00 $0 D/D 245,080 1,159,439     -
   Mcdermott Wendy VP, Human Resources   •       •      –    2024-02-28 4 D $2.62 $58,754 D/D (22,425) 52,694     -
   Mcdermott Wendy VP, Human Resources   •       •      –    2024-02-28 4 OE $0.00 $0 D/D 46,641 75,119     -
   Crum Brian T SVP, General Counsel & Secr.   •       •      –    2024-02-28 4 D $2.62 $67,082 D/D (25,604) 177,497     -
   Crum Brian T SVP, General Counsel & Secr.   •       •      –    2024-02-28 4 OE $0.00 $0 D/D 68,303 203,101     -
   Alexander Kristen VP, Finance and Accounting   •       •      –    2024-02-28 4 D $2.62 $30,898 D/D (11,793) 47,800     -
   Alexander Kristen VP, Finance and Accounting   •       •      –    2024-02-28 4 OE $0.00 $0 D/D 29,243 59,593     -
   Main Alan J EVP, Innov & Chem Sciences   •       •      –    2024-02-28 4 D $2.62 $63,949 D/D (24,408) 255,724     -
   Main Alan J EVP, Innov & Chem Sciences   •       •      –    2024-02-28 4 OE $0.00 $0 D/D 67,546 280,132     -
   Kassler-Taub Kenneth B. SVP, Regulatory & QA   •       •      –    2024-02-28 4 D $2.62 $63,805 D/D (24,353) 162,672     -
   Kassler-Taub Kenneth B. SVP, Regulatory & QA   •       •      –    2024-02-28 4 OE $0.00 $0 D/D 67,400 187,025     -
   Granowitz Craig B SVP, Chief Medical Officer   •       •      –    2024-02-28 4 D $2.62 $81,914 D/D (31,265) 47,626     -
   Granowitz Craig B SVP, Chief Medical Officer   •       •      –    2024-02-28 4 OE $0.00 $0 D/D 63,706 78,891     -
   Wade Jeffrey L President and CFO   •       •      –    2024-02-28 4 D $2.62 $98,750 D/D (37,691) 324,214     -
   Wade Jeffrey L President and CFO   •       •      –    2024-02-28 4 OE $0.00 $0 D/D 97,564 361,905     -
   Coats Lonnel Chief Executive Officer   •       •      –    2023-11-16 4 B $1.05 $94,797 D/D 90,000 914,359 2.81 87%     
   Amouyal Philippe Director   •       •      –    2023-11-13 4 B $1.01 $201,520 D/D 200,000 240,332 2.39 98%     
   Coats Lonnel Chief Executive Officer   •       •      –    2023-11-10 4 B $1.01 $10,100 D/D 10,000 824,359 2.81 124%     
   Debbane Raymond Director   •       •      –    2023-10-12 4 B $1.03 $153,805 D/D 148,820 1,340,847 2.39 128%     
   Debbane Raymond Director   •       •      –    2023-10-11 4 B $1.08 $370,784 D/D 342,874 1,192,027 2.39 135%     
   Debbane Raymond Director   •       •      –    2023-10-10 4 B $1.14 $579,367 D/D 508,306 849,153 2.39 137%     
   Wade Jeffrey L President and CFO   •       •      –    2023-09-14 4 B $1.38 $13,800 D/D 10,000 264,341 2.74 29%     
   Mcdermott Wendy VP, Human Resources   •       •      –    2023-08-04 4 B $1.84 $11,040 D/D 6,000 28,478 2.74 -37%     

  301 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 13
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed